<code id='8FBC259382'></code><style id='8FBC259382'></style>
    • <acronym id='8FBC259382'></acronym>
      <center id='8FBC259382'><center id='8FBC259382'><tfoot id='8FBC259382'></tfoot></center><abbr id='8FBC259382'><dir id='8FBC259382'><tfoot id='8FBC259382'></tfoot><noframes id='8FBC259382'>

    • <optgroup id='8FBC259382'><strike id='8FBC259382'><sup id='8FBC259382'></sup></strike><code id='8FBC259382'></code></optgroup>
        1. <b id='8FBC259382'><label id='8FBC259382'><select id='8FBC259382'><dt id='8FBC259382'><span id='8FBC259382'></span></dt></select></label></b><u id='8FBC259382'></u>
          <i id='8FBC259382'><strike id='8FBC259382'><tt id='8FBC259382'><pre id='8FBC259382'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:94
          Cynthia Fisher on stage at the 2023 STAT Summit.
          Cynthia Fisher, founder and chairman, PatientRightsAdvocate.org STAT

          BOSTON — For all those who think hospital price transparency will not save money, Cynthia Fisher has a message: it’s already doing so.

          Fisher, who spoke Wednesday at the annual STAT Summit in Boston, is the successful entrepreneur and founder of PatientRightsAdvocate.org who has been leading an unorthodox campaign to get hospitals to disclose prices.

          advertisement

          The campaign has made progress. Republicans on three House committees introduced a bill to make hospitals disclose prices up front, though then-House Speaker Kevin McCarthy (R-Calif.) pulled the bill shortly before it was supposed to receive a vote on the House floor.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted
          FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

          DarronCummings/APScientistsattheFoodandDrugAdministrationhavetwobigquestionsaboutEliLilly’sexperimen

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Curing rare childhood diseases will falter unless Congress steps up

          AdobeWhenoursonPeterwasdiagnosedwithanultra-rareformofmusculardystrophyattheageof10,thefirstquestion